1. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006; 7:41–53. PMID:
16371949.
Article
2. Beaumont A, Marmarou A, Hayasaki K, Barzo P, Fatouros P, Corwin F, et al. The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir Suppl. 2000; 76:125–129. PMID:
11449990.
Article
3. Becker DP, Miller JD, Ward JD, Greenberg RP, Young HF, Sakalas R. The outcome from severe head injury with early diagnosis and intensive management. J Neurosurg. 1977; 47:491–502. PMID:
903803.
Article
4. Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int Suppl. 1999; S62–S66.
Article
5. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001; 37:457–466. PMID:
11228168.
Article
6. Davenport A, Will EJ, Losowsky MS, Swindells S. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure. Br Med J (Clin Res Ed). 1987; 295:1028.
Article
7. De Corte W, Vanholder R, Dhondt AW, De Waele JJ, Decruyenaere J, Danneels C, et al. Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy. Nephrol Dial Transplant. 2011; 26:3211–3218. PMID:
21421593.
Article
8. Fletcher JJ, Bergman K, Carlson G, Feucht EC, Blostein PA. Continuous renal replacement therapy for refractory intracranial hypertension? J Trauma. 2010; 68:1506–1509. PMID:
20539193.
Article
9. Fletcher JJ, Bergman K, Feucht EC, Blostein P. Continuous renal replacement therapy for refractory intracranial hypertension. Neurocrit Care. 2009; 11:101–105. PMID:
19267223.
Article
10. Gibney N, Hoste E, Burdmann EA, Bunchman T, Kher V, Viswanathan R, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol. 2008; 3:876–880. PMID:
18322044.
Article
11. Härtl R, Medary M, Ruge M, Arfors KE, Ghajar J. Blood-brain barrier breakdown occurs early after traumatic brain injury and is not related to white blood cell adherence. Acta Neurochir Suppl. 1997; 70:240–242. PMID:
9416334.
Article
12. Li N, Zhao WG, Zhang WF. Acute kidney injury in patients with severe traumatic brain injury: implementation of the acute kidney injury network stage system. Neurocrit Care. 2011; 14:377–381. PMID:
21298359.
Article
13. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008; 7:728–741. PMID:
18635021.
Article
14. Nongnuch A, Panorchan K, Davenport A. Brain-kidney crosstalk. Crit Care. 2014; 18:225. PMID:
25043644.
Article
15. Ronco C, Bellomo R, Brendolan A, Pinna V, La Greca G. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol. 1999; 12:173–178. PMID:
10440514.
16. Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol. 2013; 9:231–236. PMID:
23443846.
Article
17. Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Nonneurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005; 33:654–660. PMID:
15753760.
Article